Century Therapeutics, Inc.

NASDAQ:IPSC

1.1 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -136.673-130.932-95.824-53.575-244.769
Depreciation & Amortization 13.0448.443.7481.4020.249
Deferred Income Tax 0004.7220
Stock Based Compensation 14.62210.6694.6620.8760.147
Change In Working Capital 9.38123.945-2.7974.8622.259
Accounts Receivables 00000
Inventory 00000
Accounts Payables -2.361-4.788-1.8482.0621.233
Other Working Capital 11.741128.733-0.9492.81.026
Other Non Cash Items 11.2791.931.2090.444225.946
Operating Cash Flow -88.34814.052-89.002-41.269-16.168
Investing Activities:
Investments In Property Plant And Equipment -13.736-30.604-44.97-9.825-2.46
Acquisitions Net 0-238.218-30.336-4.72224.166
Purchases Of Investments -209.034-254-330.034-49.86-41.54
Sales Maturities Of Investments 283.902271.47676.66641.65-24.166
Other Investing Activites 0238.21830.336-4.72224.166
Investing Cash Flow 61.132-13.128-298.338-22.757-19.834
Financing Activities:
Debt Repayment -10.241009.7340
Common Stock Issued 0.51627.158221.61538.174.839
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities 00196.15937.95674.839
Financing Cash Flow -9.72527.158417.77447.6974.839
Other Information:
Effect Of Forex Changes On Cash 00000
Net Change In Cash -36.94128.08230.434-16.33638.837
Cash At End Of Period 49.30386.24458.16227.72870.261